e.l.f. Beauty news

Company demonstrates strong fundamentals with 24.6% YoY revenue growth, 30 consecutive quarters of sales growth, and recent quarter showing 36% growth. However, sentiment is moderated by high P/E ratio (102.45), low net margins (1.6%), heavy reliance on third-party manufacturers, and customer concentration risk with major retailers.

Mixed signals: near-term earnings per share expected to decline 13.24%, but strong revenue growth of 36.08% projected for the upcoming quarter and solid full-year growth estimates (16.29% earnings, 20.16% revenue). Stock underperforming broader market with a Hold rating and premium valuation relative to industry peers. No recent analyst estimate revisions suggest limited near-term catalyst.

Despite bullish Wall Street recommendations (ABR 1.74, 63.2% Strong Buy), the Zacks Rank #3 (Hold) rating based on unchanged consensus earnings estimates of $3.64 suggests the stock should perform in line with the market. The article advises caution against the Buy-equivalent ABR, indicating neutral near-term price movement expectations.

Mixed signals: stock underperformed broader market on the day and EPS is expected to decline 10.29% YoY, but revenue growth is strong at 36.08% and the stock has outperformed its sector over the past month. The Zacks Rank #3 (Hold) rating and elevated PEG ratio of 2.16 versus industry average of 0.97 suggest the stock is fairly valued with limited near-term upside.

The company is strategically expanding into Brazil, the world's third-largest cosmetics market, with strong international momentum (61% YoY growth). However, sentiment is tempered by the stock's 33.4% decline over the past year and valuation concerns (P/E of 25.76 vs. industry average of 22.15), suggesting execution risk remains.

The insider sale is non-discretionary and part of a pre-planned trading arrangement, indicating no negative signal about company prospects. The executive retains a substantial equity stake (138,797 shares), demonstrating continued confidence. However, the stock declined 16% over the trailing 12 months, though it has recovered after the company raised growth guidance to 18-20%, showing mixed but improving momentum.

While the company delivered strong Q1 earnings with a 36% sales beat, raised full-year guidance, and benefited from Rhode momentum, post-earnings estimate revisions have declined 21.54%. The Zacks Rank #3 (Hold) rating and expectation for in-line returns suggest limited upside despite recent stock appreciation, indicating the positive catalysts may already be priced in.

Despite a 53% decline from all-time highs, the company shows booming sales and aggressive market share expansion strategy. The Motley Fool recommends the stock, and recent performance (Rhode brand surge) suggests potential recovery. The sell-off appears to be viewed as an overreaction by analysts.

The company faces slowing organic growth, increased operating expenses from tariffs and inflationary pressures, and maturing business fundamentals. Despite appearing cheap on valuation metrics, the analyst expects stock stagnation without acceleration in organic growth.

Demonstrates impressive 24.6% revenue growth to $1.6B, but profitability is weak with only 1.6% net margin. High customer concentration risk with major retailers (Target, Walmart, Amazon) accounting for substantial sales. Higher valuation at 29.3x forward P/E. Not recommended over Amazon despite faster growth.

The company demonstrates strong momentum with 30 consecutive quarters of sales growth (24.6% YoY), a significant earnings beat, successful Rhode acquisition integration, surging international revenue, and market share gains. The author explicitly recommends it as 'the stronger pick' for long-term investors due to accelerating growth and brand momentum.

Strong Q1 earnings beat (36% revenue growth vs. consensus), significant guidance raises, successful Rhode acquisition contributing $160M in sales, multiple growth drivers (Sephora expansion, hair care entry, international expansion), and attractive valuation at forward P/E under 25 support positive outlook.

Strong 32% stock jump in June, 35% year-over-year sales growth, successful market share gains (9.2 percentage points in makeup), new hair care line with 96% positive sentiment, Rhode acquisition performing well, and potential $58.5 million tariff refund. Stock trades at reasonable 20x forward earnings despite being down year-to-date, presenting a buying opportunity for long-term investors.

The article highlights Rhode's product expansion as a significant growth driver, notes the brand's higher profit margins compared to e.l.f.'s main line, emphasizes strong social media promotion by Hailey Bieber with 58 million followers, and values the stock at a reasonable forward P/E of 16 with substantial upside potential from future distribution expansion.

Mixed signals: strong operational performance (35% revenue growth, 29 consecutive quarters of sales growth, Rhode brand success) and attractive valuation (14x forward sales) are offset by tariff uncertainty, unit sales declines from price increases, and ongoing market volatility. The stock fell despite beating earnings, indicating investor concern about forward guidance and tariff resolution timing.

Strong revenue growth of 35% YoY, Rhode brand performing exceptionally well with 80% annual growth, attractive forward P/E ratio of 15.5, significant expansion runway in Sephora stores (only 20% penetration), anticipated tariff reduction from 55% to 35% providing pricing flexibility, and positive full-year guidance of 14-17% revenue growth.

Stock is trading at deep-value levels after 65% decline with multiple catalysts in play. Favorable test results showing 35% volume growth from price reductions, strong technical support levels, analyst consensus forecasting 70% upside, and 95% institutional ownership indicate strong recovery potential. Despite tepid guidance, the company is positioned for rebound in the back half of 2026 and beyond.

Company beat Q4 earnings and revenue estimates, demonstrated strong year-over-year growth of 35%, achieved seven consecutive years of industry-leading results, and the Rhode acquisition is performing exceptionally well with over $500 million in global retail sales. However, fiscal 2027 guidance came in slightly below analyst expectations, which provides a minor offset to the otherwise strong results.

Strong Q4 earnings and revenue beats with 35% year-over-year growth, 140 basis point gross margin improvement, and seven consecutive years of net sales and market share growth. Stock rallied 7.39% on the results. However, sentiment is tempered by fiscal 2027 guidance that missed analyst expectations on both EPS and revenue, which may limit upside momentum.

Despite current headwinds, the company demonstrates strong fundamentals with 38% revenue growth, significant market share gains (8% in color cosmetics, 16% in skincare), successful Rhode brand acquisition, and analyst consensus showing 58% upside potential. Stock valuation at 31x earnings is substantially below historical averages, suggesting oversold conditions and attractive entry point for long-term investors.

Stock experienced severe short-term decline (34.2% in March) due to geopolitical pressures and rising input costs, but is showing recovery momentum in April (5.3% gain) as war tensions de-escalate. Outlook remains uncertain with ongoing geopolitical risks.

Despite revenue growth, the company faces significant headwinds from rising tariffs that have eroded profit margins by 33% over three years, making earnings unreliable. The stock remains expensive on an absolute basis (45x P/E vs S&P 500's 28x), and the author recommends most investors stay on the sidelines until earnings trend consistently higher.

Seven consecutive years of market share gains with 25% net sales growth despite 22% year-to-date stock decline. Strong brand popularity, explosive skincare growth, and improving free cash flow ($190M trailing-12-month) suggest analyst expectations of 10% earnings growth are too conservative given expansion potential.

Jumped 7.8% in relief bounce after quarterly report despite cautious guidance and potential $15-20M hit from higher oil prices; maintained bullish analyst ratings

Company demonstrates consistent double-digit growth for 29 consecutive quarters, successful strategic acquisitions (Naturium and rhode), 25% year-over-year net sales growth, and expanding international presence outpacing legacy competitors like L'Oréal and Estée Lauder.

Reported earnings of 32 cents per share beating consensus of 29 cents, and revenue of $449.29 million exceeding Street estimate of $422.93 million; stock jumped 9%

Positioned as a cheap growth stock with attractive forward P/E of 15.5x, leveraging successful distribution strategy to expand Rhode skincare brand into new retail outlets.

Q2 insider sales of $13 million all came with mitigating factors. CEO's sale was under a 10b5-1 plan, and other sales resulted from vesting of performance-based restricted stock units requiring tax withholding, making them procedural rather than bearish signals.

28 consecutive quarters of net sales growth, strong value proposition with products under $15, 38% Q3 growth, expanding to 120 countries from 16, maintains 70% gross margin vs. industry average of 41%, resilient in downturns

Discounted valuation (forward P/E just above 15x) despite robust revenue growth, operates in defensive cosmetics industry, and has significant growth opportunity with Rhode brand acquisition which generated $200M+ in sales within three years.

Mentioned as a successful adopter of Google's new 'direct offers' feature for personalized promotions, indicating participation in high-performing AI ad initiatives.

Strong market share gains in mass cosmetics through low-cost products and influencer marketing. Rhode acquisition (founded by Hailey Bieber, $200M+ sales in <3 years) provides significant growth opportunity through e.l.f.'s distribution and marketing playbook. Forward P/E of 16x is attractive for a growth stock with proven execution.

Investigation launched into whether board members violated securities laws or breached fiduciary duties, indicating potential unfair treatment of long-term shareholders.

Kaskela Law is investigating whether the board violated securities laws or breached fiduciary duties, indicating potential governance concerns affecting shareholder interests.

Trading at attractive valuation with PEG ratio below 0.4 (undervalued threshold is 1.0). Strong growth opportunity from Rhode skincare brand acquisition with expanding Sephora distribution and significant upside potential from increased product assortment and marketing.

Despite a 67% stock decline from highs, the company demonstrates strong fundamentals with 38% YoY sales growth, expanding market share at major retailers like Walmart, and scaling from $578M to $1.52B in trailing-12-month revenue over three years. Forward P/E of 24 is considered attractive for a fast-growing consumer brand.